ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Team Lead, OpenADMET at Octant Bio - ApplyBlast

Team Lead, OpenADMET

Octant Bio

20 days ago

Emeryville, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Octant is seeking a Team Lead to head the OpenADMET consortium, a multi-institution open science initiative focused on solving ADMET prediction and making it a design challenge. This role involves leading strategy and execution for Octant's contributions, coordinating with partners like UCSF and OMSF, and integrating OpenADMET workflows into the company's drug discovery programs. The position requires a leader who can bridge strategic vision with hands-on execution in a fast-paced, collaborative environment.

Responsibilities

Lead strategy and execution for Octant's contributions to OpenADMET consortium
Build and onboard robust high-throughput ADMET assays for drug discovery programs
Connect in-house synthesis capabilities with ADMET assays in a closed design-make-test loop

Skills

Qualifications

PhD in Analytical ChemistryPhD in Medicinal ChemistryPhD in Pharmaceutical SciencesPhD in ChemistryPhD in Biology

About Octant Bio

octant.bio

Headquarters

Emeryville, California, United States

Company Size

51-200 employees

Founded

2017

View Profile

Octant is a biotechnology company that combines next‑generation biology, chemistry, and computation to engineer precision medicines. The company focuses on next‑generation small‑molecule therapeutics that modulate complex cellular mechanisms driving disease, rather than only binding purified protein targets. Octant builds and applies large‑scale biology and chemistry platforms aimed at correcting diseases of protein misfolding and mistrafficking. Their platform‑driven approach expands which cellular processes can be drugged to create new treatment opportunities.